Forbes

Perhaps if America’s best athletes played soccer, the men’s team would be better. But it's doubtful as this view narrowly focuses on particular forms of athleticism.

The partnership brings quantitative MRI into real-time clinical workflows, helping neurologists track disease progression and make treatment decisions.

A doctor explains what cyclosporiasis is, what symptoms to look out for, and how to keep your loved ones protected.

A rare bacteria was found in a Wyoming City's water supply and traced to wastewater coming from an under-construction Meta AI data center.

A doctor breaks down the latest WHO report on cancer and explains why inequities, and not science, could be the biggest threat to the increased cancer burden globally.

IRS opens Kwong portal for electronic Form 843 claims as key refund deadlines approach. Taxpayers should review filing and payment dates before July 10.

AI has become a silent third participant in therapy. Data shows most psychologists now have patients turning to chatbots between sessions.

Instituting a cap on Medicare out-of-pocket expenses would likely help limit financial toxicity experienced by patients and their families due to high healthcare costs.

Mamatoto Village has maintained a 0% maternal mortality rate, supporting thousands of families. We spoke with co-founder Aza Nedhari to learn more.

In this week’s edition of InnovationRx, we look at the boom in autoimmune disease therapies, OpenAI’s healthcare push, Vertex’s $10 billion purchase of Crinetics, and more.

Health insurers selling Obamacare are proposing another year of double-digit percentage premium increases for 2027, a new KFF analysis shows.

The new White House Office of Management and Budget rule would give Trump and his administration significantly more power to select, award, cut and terminate grants,

Multiple new clinical trials are underway to evaluate if various treatments will prove effective against the Bundibugyo Ebola virus in the DRC. A

Cigna’s $100 million investment to support a new AI-powered pharmacy program and Peak Rock Capital's purchase of Asembia may spur even more specialty pharmacy deals.